Cargando…
Clozapine rechallenge or continuation despite neutropenia or agranulocytosis using colony-stimulating factor: A systematic review
OBJECTIVES: Rechallenge/continuation of clozapine in association with colony-stimulating factors (CSFs) following neutropenia/agranulocytosis has been reported, but many questions remain unanswered about efficacy and safety. This systematic review aims to assess the efficacy and safety of rechalleng...
Autores principales: | Corbeil, Olivier, Béchard, Laurent, Fournier, Émilien, Plante, Maude, Thivierge, Marc-André, Lafrenière, Charles-Émile, Huot-Lavoie, Maxime, Brodeur, Sébastien, Essiambre, Anne-Marie, Roy, Marc-André, Demers, Marie-France |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363950/ https://www.ncbi.nlm.nih.gov/pubmed/36794520 http://dx.doi.org/10.1177/02698811231154111 |
Ejemplares similares
-
Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series
por: Béchard, Laurent, et al.
Publicado: (2021) -
S1. CLOZAPINE RECHALLENGE FOLLOWING NEUTROPENIA USING GRANULOCYTE COLONY-STIMULATING FACTOR: A QUEBEC CASE SERIES
por: Béchard, Laurent, et al.
Publicado: (2020) -
Management of Rhabdomyolysis in a Patient Treated with Clozapine: A Case Report and Clinical Recommendations
por: Béchard, Laurent, et al.
Publicado: (2022) -
Problem gambling among people with first-episode psychosis: protocol for a prospective multicenter cohort study
por: Corbeil, Olivier, et al.
Publicado: (2023) -
Real-life effectiveness of transitioning from paliperidone palmitate
1-monthly to paliperidone palmitate 3-monthly long-acting injectable
formulation
por: Corbeil, Olivier, et al.
Publicado: (2022)